Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse
- PMID: 17662610
- PMCID: PMC2245889
- DOI: 10.1016/j.nbd.2007.06.015
Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse
Abstract
The impact of Abeta deposition upon cholinergic intrinsic cortical and striatal, as well as basal forebrain long projection neuronal systems was qualitatively and quantitatively evaluated in young (2-6 months) and middle-aged (10-16 months) APPswe/PS1DeltaE9 transgenic (tg) mice. Cholinergic neuritic swellings occurred as early as 2-3 months of age in the cortex and hippocampus and 5-6 months in the striatum of tg mice. However, cholinergic neuron number or choline acetyltransferase (ChAT) optical density measurements remained unchanged in the forebrain structures with age in APPswe/PS1DeltaE9 tg mice. ChAT enzyme activity decreased significantly in the cortex and hippocampus of middle-aged tg mice. These results suggest that Abeta deposition has age-dependent effects on cortical and hippocampal ChAT fiber networks and enzyme activity, but does not impact the survival of cholinergic intrinsic or long projection forebrain neurons in APPswe/PS1DeltaE9 tg mice.
Figures








Similar articles
-
The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.Neuroscience. 2004;125(3):769-76. doi: 10.1016/j.neuroscience.2004.01.050. Neuroscience. 2004. PMID: 15099690
-
Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.Invest Ophthalmol Vis Sci. 2009 Feb;50(2):793-800. doi: 10.1167/iovs.08-2384. Epub 2008 Sep 12. Invest Ophthalmol Vis Sci. 2009. PMID: 18791173 Free PMC article.
-
Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.J Neurosci. 2002 Apr 15;22(8):3234-43. doi: 10.1523/JNEUROSCI.22-08-03234.2002. J Neurosci. 2002. PMID: 11943824 Free PMC article.
-
The cholinergic system in aging and neuronal degeneration.Behav Brain Res. 2011 Aug 10;221(2):555-63. doi: 10.1016/j.bbr.2010.11.058. Epub 2010 Dec 9. Behav Brain Res. 2011. PMID: 21145918 Review.
-
Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice.Neuropeptides. 2005 Jun;39(3):233-7. doi: 10.1016/j.npep.2004.12.005. Epub 2005 Feb 1. Neuropeptides. 2005. PMID: 15893372 Review.
Cited by
-
Chemical genetic activation of the cholinergic basal forebrain hippocampal circuit rescues memory loss in Alzheimer's disease.Alzheimers Res Ther. 2022 Apr 13;14(1):53. doi: 10.1186/s13195-022-00994-w. Alzheimers Res Ther. 2022. PMID: 35418161 Free PMC article.
-
Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model.Glia. 2021 Aug;69(8):1852-1881. doi: 10.1002/glia.23981. Epub 2021 Feb 25. Glia. 2021. PMID: 33634529 Free PMC article.
-
Specific serotonergic denervation affects tau pathology and cognition without altering senile plaques deposition in APP/PS1 mice.PLoS One. 2013 Nov 21;8(11):e79947. doi: 10.1371/journal.pone.0079947. eCollection 2013. PLoS One. 2013. PMID: 24278223 Free PMC article.
-
Acute Down-regulation of BDNF Signaling Does Not Replicate Exacerbated Amyloid-β Levels and Cognitive Impairment Induced by Cholinergic Basal Forebrain Lesion.Front Mol Neurosci. 2018 Feb 22;11:51. doi: 10.3389/fnmol.2018.00051. eCollection 2018. Front Mol Neurosci. 2018. PMID: 29520217 Free PMC article.
-
Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development.Eur J Neurosci. 2009 Dec;30(12):2271-83. doi: 10.1111/j.1460-9568.2009.07017.x. Epub 2009 Dec 10. Eur J Neurosci. 2009. PMID: 20092570 Free PMC article.
References
-
- Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer’s disease. J Neurochem. 1988;50:1914–1923. - PubMed
-
- Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex. 1991;1:103–116. - PubMed
-
- Aucoin JS, Jiang P, Aznavour N, Tong XK, Buttini M, Descarries L, Hamel E. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer’s disease. Neuroscience. 2005;132:73–86. - PubMed
-
- Bayraktar T, Staiger JF, Acsady L, Cozzari C, Freund TF, Zilles K. Colocalization of vasoactive intestinal polypeptide, gamma-aminobutyric acid and choline acetyltransferase in neocortical interneurons of the adult rat. Brain Res. 1997;757:209–217. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous